$ONCT Oncternal Therapeutics Inc Target PT 11 and higherNASDAQ:ONCT Oncternal Therapeutics Inc
Target PT 11 and higher
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanize